Fast Market Research announces the availability of the new TechNavio report, "Global Endocrinology Drugs Market 2016-2020", on their comprehensive research portal

Boston, MA -- (SBWire) -- 05/11/2016 --Endocrinology deals with the study of the endocrine system, including the biochemical and physiological functions of the hormones, cells, and tissues of the endocrine glands. Endocrine disorders can be broadly subdivided into three categories: endocrine gland hyposecretion, which causes hormone deficiency, endocrine gland hypersecretion, which causes excess hormone secretion, and tumors in the endocrine gland. The endocrine disorders considered for the present report include diabetes, human growth hormone deficiency, thyroid disorders, and male hypogonadism.

Technavio's analysts forecast the global endocrinology drugs market to grow at a CAGR of 6.69% during the period 2016-2020.

Get More Details on this Report and a Full Table of Contents at Global Endocrinology Drugs Market 2016-2020

Covered in this report
The report covers the present scenario and the growth prospects of the global endocrinology drugs market for 2015-2020. To calculate the market size, the report considers revenue generated from the sales of branded drugs, generics, and biosimilars used to treat and prevent type 1 and type 2 diabetes, human growth hormone deficiency, hypogonadism, and thyroid gland disorders.

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Endocrinology Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-AbbVie Inc.
-AstraZeneca PLC
-Eli Lilly and Co.
-Merck & Co
-Novo Nordisk AS
-Sanofi SA

Other prominent vendors

-Acerus Pharmaceuticals
-Acrux DDS
-Adocia
-Aeterna Zentaris
-Akros Pharma
-Allergan
-Amgen
-Antares Pharma
-Ascendis Pharma
-Astellas Pharma
-Baxalta
-Bayer HealthCare Pharmaceuticals
-BHV Pharma
-Biocon
-Biodel
-Boehringer Ingelheim
-ChipScreen Biosciences
-Clarus Therapeutics
-ConjuChem
-Critical Pharmaceuticals
-CureDm
-CymaBay Therapeutics
-Daiichi Sankyo
-Dance Biopharm
-DiaMedica
-Diamyd Therapeutics
-Diasome Pharmaceuticals
-DiaVacs
-Dong-A ST
-Eisai
-Elcelyx Therapeutics
-Endo Pharmaceuticals
-Exsulin
-Ferring Pharmaceuticals
-Gan & Lee Pharmaceuticals
-Genentech
-Generex
-Genexine
-Genfit
-GSK
-HanAll BioPharma
-Hanmi Pharmaceutical
-Hua Medicine
-ILTOO Pharma
-Intarcia Therapeutics
-InteKrin Therapeutics
-Intrexon
-Ionis Pharmaceuticals
-Ipe
-Islet Sciences
-Janssen Pharmaceuticals
-Japan Tobacco
-Juniper Pharmaceuticals
-Kadmon Corporation
-Kamada
-KinDex Pharmaceuticals
-Kissei Pharmaceutical
-Kotobuki
-Lexicon Pharmaceuticals
-LG Life Sciences
-Ligand Pharmaceuticals
-Lipocine
-Living Cell Technologies
-MacroGenics
-MannKind
-MedImmune
-Melior Pharmaceuticals
-Metabolic Solutions Development Company
-MetP Pharma
-Mitsubishi Tanabe Pharma
-Mylan
-NGM Biopharmaceuticals
-Novartis
-NuSirt Biopharma
-OPKO Biologics
-Oramed Pharmaceuticals
-Osiris Therapeutics
-Peptron
-Perle Biosciences
-Pfizer
-PhaseBio Pharmaceuticals
-Poxel
-ProStrakan Group
-REGiMMUNE
-Repros Therapeutics
-Roche
-Sanwa Kagaku Kenkyusho
-Sirona Biochem
-Strongbridge Biopharma
-Takeda Pharmaceuticals
-TesoRx Pharma
-Teva Pharmaceutical
-Theracos
-Theratechnologies
-Toleranzia
-Tolerion
-Transition Therapeutics
-VeroScience
-Versartis
-vTv Therapeutics
-XBiotech
-Xeris Pharmaceuticals
-XOMA

Market driver

-Increase in prevalence of endocrine hormone-related diseases
-For a full, detailed list, view our report

Market challenge

-Generic erosion
-For a full, detailed list, view our report

Market trend

-Increase in outsourcing
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2020 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?

Companies Mentioned in this Report: AbbVie Inc., AstraZeneca PLC, Eli Lilly and Co., Merck & Co, Novo Nordisk AS, Sanofi SA, Acerus Pharmaceuticals, Acrux DDS, Adocia, Aeterna Zentaris, Akros Pharma, Allergan, Amgen, Antares Pharma, Ascendis Pharma, Astellas Pharma, Baxalta, Bayer HealthCare Pharmaceuticals, BHV Pharma, Biocon, Biodel, Boehringer Ingelheim, ChipScreen Biosciences, Clarus Therapeutics, ConjuChem, Critical Pharmaceuticals, CureDm, CymaBay Therapeutics, Daiichi Sankyo, Dance Biopharm, DiaMedica, Diamyd Therapeutics, Diasome Pharmaceuticals, DiaVacs, Dong-A ST, Eisai, Elcelyx Therapeutics, Endo Pharmaceuticals, Exsulin, Ferring Pharmaceuticals, Gan & Lee Pharmaceuticals, Genentech, Generex, Genexine, Genfit, GSK, HanAll BioPharma, Hanmi Pharmaceutical, Hua Medicine, ILTOO Pharma, Intarcia Therapeutics, InteKrin Therapeutics, Intrexon, Ionis Pharmaceuticals, Ipe, Islet Sciences, Janssen Pharmaceuticals, Japan Tobacco, Juniper Pharmaceuticals, Kadmon Corporation, Kamada, KinDex Pharmaceuticals, Kissei Pharmaceutical, Kotobuki, Lexicon Pharmaceuticals, LG Life Sciences, Ligand Pharmaceuticals, Lipocine, Living Cell Technologies, MacroGenics, MannKind, MedImmune, Melior Pharmaceuticals, Metabolic Solutions Development Company, MetP Pharma, Mitsubishi Tanabe Pharma, Mylan, NGM Biopharmaceuticals, Novartis, NuSirt Biopharma, OPKO Biologics, Oramed Pharmaceuticals, Osiris Therapeutics, Peptron, Perle Biosciences, Pfizer, PhaseBio Pharmaceuticals, Poxel, ProStrakan Group, REGiMMUNE, Repros Therapeutics, Roche, Sanwa Kagaku Kenkyusho, Sirona Biochem, Strongbridge Biopharma, Takeda Pharmaceuticals, TesoRx Pharma, Teva Pharmaceutical, Theracos, Theratechnologies, Toleranzia, Tolerion, Transition Therapeutics, VeroScience, Versartis, vTv Therapeutics, XBiotech, Xeris Pharmaceuticals, XOMA.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research